Miskolc, Hungary Clinical Trials

A listing of Miskolc, Hungary clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 72 clinical trials
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

This study is designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis (UC).

mirikizumab
Endomedix Diagnosztikai Kozpont
 (1.1 away) Contact site
  • 257 views
  • 22 Sep, 2021
  • +620 other locations
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

This research study is done to test how well different types of cancer respond to the drug called larotrectinib. The cancer must have a change in a particular gene (NTRK1, NTRK2 or NTRK3). Larotrectinib is a drug that blocks the actions of these NTRK genes in cancer cells and can …

breast cancer
lung cancer
measurable disease
NTRK
tyrosine
Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz
 (1.4 away) Contact site
  • 0 views
  • 15 Sep, 2021
  • +204 other locations
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo in the treatment of participants in heart failure with a reduced ejection fraction and with iron deficiency

bypass graft
b-type natriuretic peptide
nt-probnp
natriuretic peptide
iron
Andrea Hornyik, MD
 (0.8 away) Contact site
  • 5333 views
  • 20 Aug, 2021
  • +365 other locations
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over express c-Met (c-Met+) best suited for telisotuzumab vedotin therapy in the second line or third line setting (Stage 1) and then to expand the group(s) to further evaluate efficacy in the selected population(s) (Stage …

c-MET
stage iv non-small cell lung cancer
epidermal growth factor receptor
cancer chemotherapy
tyrosine
CRU Hungary Egeszsegugyi s Szolgaltato Kft. /ID# 204878
 (0.8 away) Contact site
  • 119 views
  • 21 Sep, 2021
  • +380 other locations
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN (NCT03518086).

mirikizumab
endoscopy
Endomedix Diagnosztikai Kozpont
 (1.1 away) Contact site
  • 386 views
  • 22 Sep, 2021
  • +912 other locations
Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection

The purpose of this study is to evaluate the antiviral activity, clinical outcomes, safety, tolerability, and pharmacokinetic/pharmacodynamic relationships of different oral dose levels of JNJ-53718678 in children greater than or equal to 28 days and less than or equal to 3 years of age with respiratory syncytial virus (RSV) disease …

antivirals
respiratory tract infection
jnj-53718678
Futurenest Klinikai Kutato Kft.
 (1.7 away) Contact site
  • 97 views
  • 09 Sep, 2021
  • +326 other locations
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or IIA Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)

The purpose of this study is to assess the efficacy and safety of stereotactic body radiotherapy (SBRT) plus pembrolizumab (MK-3475) in the treatment of adult participants with unresected stage I or IIA non-small cell lung cancer (NSCLC). The primary study hypotheses are: SBRT plus pembrolizumab prolongs Event-free Survival (EFS) compared …

mk-3475
pembrolizumab
stereotactic body radiation therapy
lung carcinoma
CRU Hungary KFT ( Site 2309)
 (0.8 away) Contact site
  • 121 views
  • 22 Sep, 2021
  • +179 other locations
Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis

This Phase IIa study aims at investigating the safety and tolerability of 2 dose-levels of ABX464 administered daily in combination with methotrexate (MTX) in patients with moderate to severe active Rheumatoid Arthritis (RA) who had an inadequate response to MTX or/and to one or more anti- tumor necrosis factor alpha …

rheumatoid factor
methotrexate
rheumatism
tumour necrosis
tumor necrosis factor alpha
Complex Medical Centre - D li Klinika
 (90.5 away) Contact site
  • 3 views
  • 27 Jan, 2021
  • +34 other locations
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

The study is conducted to evaluate the efficacy, safety, and tolerability of two doses of K0706 compared to placebo in subjects with early Parkinson's Disease who are not receiving dopaminergic therapy.

early parkinson's
Borsod-Aba j-Zempl n Megyei K rh z s Egyetemi Oktat K rh z Neurol giai s Pszichi triai Int zet
 (1.4 away) Contact site
  • 148 views
  • 28 Jun, 2021
  • +137 other locations
MenABCWY Noninferiority Study in Healthy Participants 10 to <26 Years of Age

The aim of this study is to determine the immunologic noninferiority of MenABCWY to licensed vaccines Trumenba and MenACWY-CRM (Menveo) by assessing the safety and immunogenicity of MenABCWY and the comparators in both ACWY-nave and ACWY-experienced healthy participants 10 to <26 years of age.

CRU Hungary Kft.
 (0.8 away) Contact site
  • 320 views
  • 25 Aug, 2021
  • +96 other locations